PETALING JAYA: Sime Darby Oils (SDO), the downstream unit of Sime Darby Plantation Bhd announced a collaboration via a memorandum of agreement with Universiti Kebangsaan Malaysia (UKM) to begin the world’s first clinical trial to determine tocotrienols which is derived from palm oil could be used as a therapeutic approach for the treatment of non-alcoholic fatty liver disease (NAFLD).
“This is potentially a very exciting development for us which if the results are favorable could lead to tocotrienols being prescribed as a medicine for NAFLD, ” SDO’s managing director, Mohd Haris Mohd Arshad said at a press conference after the announcement yesterday.
